A study for a 54 year old man who takes Celexa, Tadalafil (an AI-powered real world drug study)
Summary:
110 males aged 54 (±5) who take the same drugs and have adverse effects are studied. This is a phase IV clinical study for a 54 year old male patient who has Depression, Ed. The study is created by eHealthMe based on reports from sources including the FDA.
110 males aged 54 (±5) who take Celexa, Tadalafil and have adverse effects are studied.
Number of reports submitted per year:

Information of the patient in this study:
- Age: 54
- Gender: male
What are the drugs?
- Celexa has active ingredients of citalopram hydrobromide. It is often used in depression. eHealthMe is studying from 56,390 Celexa users. Check the latest studies of Celexa.
- Tadalafil has active ingredients of tadalafil. It is often used in erection problems. eHealthMe is studying from 25,549 Tadalafil users. Check the latest studies of Tadalafil.
What are the conditions?
- Depression is found to be associated with 3,167 drugs and 4,128 conditions by eHealthMe. Check the latest studies of Depression.
- Ed is found to be associated with 1,304 drugs and 2,007 conditions by eHealthMe. Check the latest studies of Ed.
What are the adverse effects?
- Tinnitus (a ringing in the ears) is found to be associated with 1,668 drugs and 3,064 conditions by eHealthMe. Check the latest studies of Tinnitus.
Comparison with patient's specific adverse outcomes:
You can check what is more associated with an adverse outcome: a drug mix, a drug, a condition, or a population of certain gender and age. Each patient is different. It is not uncommon that the results can be inconclusive or insignificant.
By the same drug(s):
-
Tinnitus (a ringing in the ears):
- among males aged 54 (±5) who take the same drugs: 0% (0 of 110)
- among people who take the same drugs, regardless of gender or age: 0% (0 of 784)
By each condition:
-
people who have Tinnitus with Depression:
- among males aged 54 (±5) who have Depression: 1.08% (199 of 18,368)
- among people who have Depression, regardless of gender or age: 1.06% (3,635 of 344,182) -
people who have Tinnitus with Ed:
- among males aged 54 (±5) who have Ed: 1.23% (95 of 7,717)
- among people who have Ed, regardless of gender or age: 0.81% (304 of 37,458)
By each drug (FDA data only):
-
people who take Celexa and have Tinnitus:
- among males aged 54 (±5) who take Celexa and have side effects: 1.47% (37 of 2,523)
- among people who take Celexa and have side effects, regardless of gender or age: 0.63% (312 of 49,611) -
people who take Tadalafil and have Tinnitus:
- among males aged 54 (±5) who take Tadalafil and have side effects: 0.42% (6 of 1,421)
- among people who take Tadalafil and have side effects, regardless of gender or age: 0.39% (99 of 25,126)
Common drug interactions *:
- Confusional State : 18 people, 16.36%
- Nausea And Vomiting : 17 people, 15.45%
- Fatigue (feeling of tiredness): 15 people, 13.64%
- Seizures (abnormal excessive or synchronous neuronal activity in the brain): 12 people, 10.91%
- Nausea (feeling of having an urge to vomit): 12 people, 10.91%
- Dyspnea (difficult or laboured breathing): 11 people, 10.00%
- Completed Suicide (act of taking one's own life): 10 people, 9.09%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 8.18%
- Head Injury : 7 people, 6.36%
- Fainting (loss of consciousness and postural tone): 7 people, 6.36%
- Cardio-Respiratory Arrest (sudden dysfunction of heart and lungs): 6 people, 5.45%
- Herpes Zoster : 6 people, 5.45%
- Delirium (wild excitement): 6 people, 5.45%
- Overdose : 6 people, 5.45%
- Oropharyngeal Pain : 6 people, 5.45%
- Pleural Effusion (water on the lungs): 6 people, 5.45%
- Chronic Kidney Disease : 6 people, 5.45%
- Gynecomastia (enlargement of the gland tissue of the male breast): 6 people, 5.45%
- Acute Kidney Failure : 6 people, 5.45%
- Pneumonia Aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree): 5 people, 4.55%
Common co-existing conditions *:
You may use this to check any potential undetected conditions.
- Insomnia (sleeplessness): 19 people, 17.27%
- High Blood Pressure : 12 people, 10.91%
- Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 10 people, 9.09%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 10 people, 9.09%
- Pain : 8 people, 7.27%
- High Blood Cholesterol : 7 people, 6.36%
- Small Cell Lung Cancer Extensive Stage (small cell lung cancer that has spread (metastasized) to other regions of the body such as another lobe of the lung or the brain): 6 people, 5.45%
- Gastric Ulcer (stomach ulcer): 6 people, 5.45%
- Gout (uric acid crystals building up in the body): 6 people, 5.45%
- Adverse Event : 4 people, 3.64%
- Psoriasis (immune-mediated disease that affects the skin): 4 people, 3.64%
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 4 people, 3.64%
- Pulmonary Hypertension (increase in blood pressure in the lung artery): 4 people, 3.64%
- Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 3 people, 2.73%
- Type 2 Diabetes : 3 people, 2.73%
- Infection : 3 people, 2.73%
- Glioblastoma Multiforme (most common and deadliest of malignant primary brain tumours in adults): 3 people, 2.73%
- Prostatomegaly (enlargement of the prostate): 3 people, 2.73%
- Hypersensitivity : 3 people, 2.73%
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 2.73%
Common co-used drugs *:
You may use this to check any potential interacting drugs.
- Aspirin (20 people, 18.18%)
- Acetaminophen (17 people, 15.45%)
- Metformin (15 people, 13.64%)
- Metoclopramide (14 people, 12.73%)
- Escitalopram (13 people, 11.82%)
- Nexium (13 people, 11.82%)
- Oxazepam (11 people, 10.00%)
- Fish Oil (11 people, 10.00%)
- Fluconazole (10 people, 9.09%)
- Zocor (10 people, 9.09%)
- Ambien (10 people, 9.09%)
- Amlodipine (10 people, 9.09%)
- Triamcinolone (9 people, 8.18%)
- Clonazepam (9 people, 8.18%)
- Dexamethasone (9 people, 8.18%)
- Viagra (8 people, 7.27%)
- Xyrem (8 people, 7.27%)
- Tamsulosin (8 people, 7.27%)
- Ciprofloxacin (8 people, 7.27%)
- Ondansetron (8 people, 7.27%)
Drug effectiveness *:
Celexa:
n/a
Tadalafil:
n/a
* Some reports may have incomplete information.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Treatments, associated medications and conditions:
- Depression: 652,152 reports
- Ed: 80,354 reports
- Tinnitus: 58,552 reports
Drug side effects:
- Celexa and Tinnitus (312 reports)
- Tadalafil and Tinnitus (99 reports)
Drug interactions:
- Celexa and Tadalafil drug interaction (9 reports)
Symptoms:
- Depression and Tinnitus (3,635 reports)
- Ed and Tinnitus (304 reports)
Drugs that are associated with:
- Tinnitus: 1,668 drugs
Conditions that are associated with:
- Tinnitus: 3,064 conditions
How the phase IV clinical study uses the data?
The study is based on gender, age, active ingredients of any drugs used. Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Tykerb and Heat Stroke for Women aged 30-39 - 3 seconds ago
- Tykerb and Body Overheating for Women aged 30-39 - 3 seconds ago
- Tykerb and Pyrexia for Women aged 30-39 - 4 seconds ago
- Tykerb and Hyperthermia for Women aged 30-39 - 4 seconds ago
- Tykerb and Elevated Temperature for Women aged 30-39 - 4 seconds ago
- Tykerb and Fever for Women aged 30-39 - 4 seconds ago
- Drug interactions of Acyclovir and Nebivolol Hydrochloride - 7 seconds ago
- Could Sprintec cause Memory Loss? - 7 seconds ago
- Could Warfarin Sodium cause Pain? - 7 seconds ago
- Vitamins and Xanax drug interactions for women aged 30-39 - 29 seconds ago